JGRJX
Price
$40.88
Change
-$0.01 (-0.02%)
Updated
Sep 5 closing price
Net Assets
22.91B
RGACX
Price
$83.16
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

JGRJX vs RGACX

Header iconJGRJX vs RGACX Comparison
Open Charts JGRJX vs RGACXBanner chart's image
JPMorgan Growth Advantage R2
Price$40.88
Change-$0.01 (-0.02%)
VolumeN/A
Net Assets22.91B
American Funds Growth Fund of Amer R3
Price$83.16
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
JGRJX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JGRJX vs. RGACX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGRJX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 332B vs. JGRJX (22.9B). RGACX pays higher dividends than JGRJX: RGACX (0.07) vs JGRJX (0.00). JGRJX was incepted earlier than RGACX: JGRJX (8 years) vs RGACX (23 years). JGRJX (1.37) is less costly to investors than RGACX (0.94). JGRJX is a more actively managed with annual turnover of: 28.00 vs. RGACX (25.00). JGRJX has a lower initial minimum investment than RGACX: JGRJX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 17.83 vs. JGRJX (16.77). JGRJX return over 5 years is better than : 42.77 vs. RGACX (40.02).
JGRJXRGACXJGRJX / RGACX
Total Expense Ratio1.250.94133%
Annual Report Gross Expense Ratio1.370.94146%
Fund Existence8 years23 years-
Gain YTD11.02715.51671%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets22.9B332B7%
Annual Yield % from dividends0.000.07-
Returns for 1 year16.7717.8394%
Returns for 3 years75.8358.53130%
Returns for 5 years42.7740.02107%
Returns for 10 yearsN/A95.93-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CNBS29.371.19
+4.22%
Amplify Seymour Cannabis ETF
LTL109.100.99
+0.91%
ProShares Ultra Communication Services
IBTL20.660.07
+0.34%
iShares iBonds Dec 2031 Term Tr ETF
IBDQ25.120.02
+0.08%
iShares iBonds Dec 2025 Term Corp ETF
DVQQ25.08N/A
N/A
WEBs Defined Volatility QQQ ETF